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Purpose: Transferrin (Tf) expression is enhanced by aging and inflammation in humans. We investigated the role of
transferrin in glial protection.
Methods: We generated transgenic mice (Tg) carrying the complete human transferrin gene on a C57Bl/6J genetic
background. We studied human (hTf) and mouse (mTf) transferrin localization in Tg and wild-type (WT) C57Bl/6J mice
using immunochemistry with specific antibodies. Müller glial (MG) cells were cultured from explants and characterized
using cellular retinaldehyde binding protein (CRALBP) and vimentin antibodies. They were further subcultured for study.
We incubated cells with FeCl3-nitrilotriacetate to test for the iron-induced stress response; viability was determined by
direct counting and measurement of lactate dehydrogenase (LDH) activity. Tf expression was determined by reverse
transcriptase-quantitative PCR with human- or mouse-specific probes. hTf and mTf in the medium were assayed by ELISA
or radioimmunoassay (RIA), respectively.
Results: mTf was mainly localized in retinal pigment epithelium and ganglion cell layers in retina sections of both mouse
lines. hTf was abundant in MG cells. The distribution of mTf and hTf mRNA was consistent with these findings. mTf
and hTf were secreted into the medium of MG cell primary cultures. Cells from Tg mice secreted hTf at a particularly
high level. However, both WT and Tg cell cultures lose their ability to secrete Tf after a few passages. Tg MG cells
secreting hTf were more resistant to iron-induced stress toxicity than those no longer secreted hTf. Similarly, exogenous
human apo-Tf, but not human holo-Tf, conferred resistance to iron-induced stress on MG cells from WT mice.
Conclusions: hTf localization in MG cells from Tg mice was reminiscent of that reported for aged human retina and age-
related macular degeneration, both conditions associated with iron deposition. The role of hTf in protection against toxicity
in Tg MG cells probably involves an adaptive mechanism developed in neural retina to control iron-induced stress.
All cells require iron for survival and as a cofactor for a
variety of enzymes [1]. However, iron is also highly toxic due
to its ability to generate free radicals via the Fenton reaction.
Homeostatic mechanisms maintain iron levels by regulation
of the proteins involved in iron import, storage, and export,
thus  preventing  deleterious  consequences  of  either  iron
overload or deficiency.
Diseases  such  as  aceruloplasminemia  and  age-related
macular degeneration (AMD) and conditions such as siderosis
bulbi and subretinal hemorrhage are associated with increased
intraocular  iron  levels,  contributing  to  subsequent  retinal
degeneration [2–7]. The eye is particularly iron-dependent.
For instance, the extensive membrane biogenesis necessary to
replenish shed photoreceptor outer segments (OS) requires
iron as an essential cofactor [8]. Isomerization of all-trans-
retinal within the retinal pigment epithelium (RPE) in the
visual cycle requires iron for activation of RPE65, an enzyme
involved in the visual cycle pathway [9]. Moreover, being part
of the blood-retinal barrier, the RPE regulates the flow of iron
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and other nutrients between the choroidal vasculature and the
outer  retina.  The  highest  levels  of  iron  are  found  in  the
choroid, RPE, and photoreceptor inner segments (IS) and OS
in normal adult rat and human retina [10–12]. Accumulation
of iron has been observed in Royal College of Surgeons (RCS)
rats, in which phagocytosis of OS by RPE is impaired [13],
and in ceruloplasmin and hephaestin double knockout mice
[14]. The study of the roles of iron-handling proteins in the
retina will allow the normal mechanisms of iron detoxification
to be understood.
The major pathway for iron import involves the binding
of  transferrin  (Tf)  to  its  receptor  on  the  cell  surface  and
subsequent endocytosis. Tf is an extracellular protein, binding
and  transferring  iron  within  and  across  tissues.  It  is  a
ubiquitous protein with a crucial role in iron transport and iron
homeostasis [15,16]. This protein is found in the biologic
fluids of vertebrates, mainly synthesized in hepatocytes [17],
and secreted into the blood. In adults, Tf synthesis is also
found in other cell types including oligodendrocytes [18],
choroid  plexus  epithelial  [19],  Sertoli  [20],  mammary
epithelial [21], and retinal cells (including RPE) [10]. Tf may
protect the retina from the potentially toxic effects of unbound
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928iron; indeed, iron bound to Tf does not cause oxidative stress.
Finally, Tf seems to be essential for proliferation-promoting
activity of non-neuronal cells and survival of neuronal cells
[22,23].
We used a transgenic mouse (Tg) carrying the complete
human transferrin (hTf) gene to study the protective effect of
Tf against oxidative stress. In Tg mice, hTf mRNA has been
found in hepatocytes, oligodendrocytes, and Sertoli cells of
the  testis  [24].  In  testis  and  brain,  mouse  Tf  (mTf)  is
upregulated  when  compared  to  control  mice.  It  has  been
shown that myelination and maturation of oligodendrocytes
in Tg mice induce behavioral improvements [25,26]. Sixteen-
month-old Tg mice have low testicular sperm reserves without
consequence on fertility [27].
In  the  present  work,  we  first  examined  the  retinal
distribution of hTf and mTf in Tg mice and found that hTf is
produced in RPE and Müller glial (MG) cells. Second, we
isolated and cultured MG cells from Tg and wild-type (WT)
mice and examined the potential role of hTf over-production
in protecting Tg MG cells exposed to FeCl3-nitrilotriacetate
(FeCl3-NTA). Finally, we compared its action to the effects
of exogenous human apo-Tf and holo-Tf on MG cells from
WT mice.
METHODS
Animals:  Tg  mice  carrying  the  long  hTf  gene  (80  kb)
comprising its long 5′- and 3′-regulatory sequences [24] were
generated  from  the  803  line  previously  described  [26]
backcrossed in the C57Bl/6J background. They were screened
for the presence of hTf in the blood, using ELISA. All Tg mice
used in this study were homozygous for the hTf gene. Control
animals were WT C57Bl/6J mice (Janvier, Le Genest, St. Isle,
France). All mice were fed a standard laboratory diet and tap
water ad libitum and maintained in a temperature controlled
room at 21–23 °C with a 12h:12h light-dark photoperiod.
Experimental procedures were performed in accordance with
the Association for Research in Vision and Ophthalmology
(ARVO) statement for the use of animals in ophthalmology
and  vision  research  and  were  approved  by  each  author's
institutional animal care review board.
Immunohistofluorescence analysis: Freshly enucleated eyes
from  one-month-old  WT  and  Tg  mice  were  fixed  by
incubation in 4% paraformaldehyde (Inland Europe, Conflans
sur Lanterne, France) in 1X phosphate-buffered saline (PBS,
Gibco distributed by Invitrogen, Cergy Pontoise, France) for
2 h, then mounted in Tissue Tek O.C.T. (Siemens Medical,
Puteaux, France) and frozen with dry ice. Next, 10 µm frozen
sections were cut on a Leica CM3050S freezing microtome
(Leica, Rueil Malmaison, France). Sections were incubated
for 1 h with primary antibodies diluted in PBS, as follows:
1:100 rabbit polyclonal anti-mTf (Florian Guillou, INRA,
France)  [28],  1:100  rabbit  polyclonal  anti-hTf  (Florian
Guillou)  [29],  and  1:250  rabbit  anticellular  retinaldehyde
binding protein (CRALBP; received as a gift from John Saari,
University of Washington, Seattle, WA). Control sections
were incubated with non-immune rabbit serum (Invitrogen,
Cergy Pontoise, France). For CRALBP antibody, sections
were  first  blocked  with  1%  BSA  (Sigma,  Saint  Quentin
Fallavier, France) and 10% normal goat serum (Invitrogen)
before incubation with the primary antibody. An eye from a
90-year-old man (gift from Monica Valtink, Uni-Augenklinik
Dresden, University Eye Hospital, Dresden, Germany) was
mounted,  cut,  and  examined  using  the  aforedescribed
procedure, for the presence of hTf.
Sections were washed with PBS and then incubated for 1
h with secondary antibodies (goat antirabbit) labeled with
Texas Red (Jackson Laboratories distributed by TebuBio, Le
Perray  en  Yvelines,  France),  Alexa  596,  or  Alexa  488
(Invitrogen).
Nuclei  were  counterstained  with  4’,6-diamidino-2-
phenyl-indole  (Sigma).  Sections  were  analyzed  by
fluorescence  microscopy  using  a  Leica  Aristoplan  and
photographed with a Spot camera (Optilas, Evry, France),
using  identical  exposure  parameters  across  samples  to  be
compared.
Preparation of retinal extracts: Retinal extracts were obtained
by incubating 5 mg retinal tissue, obtained from one-month-
old WT and Tg mice in lysis buffer. The buffer was composed
of 15 mM Tris, pH 7.9, 60 mM KCl, 15 mM NaCl, 2 mM
EDTA, and 0.4 mM phenylmethylsulphonyl fluoride (Perbio
Science, Brebiers, France). After four successive freeze–thaw
cycles  (liquid  nitrogen-room  temperature),  lysates  were
centrifuged at 5,000x g for 10 min, and supernatants were
stored  at  –20  °C.  hTf  and  mTf  were  measured  in  equal
TABLE 1. OVERVIEW OF ALL PRIMERS USED IN THE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION.
Gene name Forward primer (5′-3′) Reverse primer (5′-3′) References
Mouse transferrin GGACGCCATGACTTTGGATG GCCATGACAGGCACTAGACC [48]
Human
transferrin
CCCTTAACCAATACTTCGGCTAC GCCAAGTTCTCAAATATAGCTGAG [59]
Mouse
β-actin
GACGGCCAAGTCATCACTATTG CCACAGGATTCCATACCCAAGA [60]
Forward and reverse primers sequences used to detect mouse and human transferrin and mouse beta actin genes with the reverse
transcriptase polymerase chain reaction method.
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929volumes of supernatant by ELISA and radioimmunoassay
(RIA),  respectively.  Results  were  reported  in  ng/ml  of
supernatant.
Transferrin quantification: hTf and mTf from retinal extracts
of WT and Tg mice were quantified by an antibody-sandwich
ELISA, as previously described [29]. The microtitration plate
was  coated  with  rabbit  anti-hTf  (Florian  Guillou),  then
different  concentrations  of  hTf  (Sigma)  or  samples  to  be
quantified were added. The plate was incubated with sheep
anti-hTf (Invitrogen) and with a peroxydase-conjugated-anti-
sheep-immunoglobin  (Sigma).  Enzyme  activity  was
determined  using  alpha-phenylenediamine  (Sigma)  as
substrate and absorbance was read at 492 nm. The minimun
limit for detection was 0.1 ng/ml. The cross-reaction rate for
hTf  antibodies  with  mTf  was  less  than  0.05%.  mTf  was
measured by RIA, as previously described [28]. RIA was set
up using 125I-labeled-mTf. The minimun limit for detection
was 1 ng/ml. The cross-reaction rate for mTf antibodies with
hTf was less than 0.0001%. All standards and samples were
assayed  in  triplicate.  The  cross-reaction  rate  for  mTf
antibodies with hTf was less than 0.0001%.
Human  transferrin  and  mouse  transferin  analysis  by RT-
qPCR:  Eyes  from  one-month-old  WT  and  Tg  mice  were
enucleated,  and  retinas  were  completely  dissected  and
homogenized using a pellet pestle motor (Dutscher, Issy les
Moulineaux, France) in lysis buffer and frozen at −80 °C after
centrifugation. Lysates were thawed and RNA isolated using
an RNeasy mini kit column (Qiagen, Courtaboeuf, France).
First  strand  cDNA  was  obtained  by  standard  reverse
transcriptase (RT) reaction (Invitrogen). Next, 150 ng RNA
was reverse transcribed for 50 min at 42 °C with 200 U
SuperScript  II  Reverse  Transcriptase  (Invitrogen)  and
oligod(T). One µl of Rnase H was added to each sample and
incubated  for  20  min  at  37  °C  before  target  cDNA
amplification. A qPCR mastermix was prepared to a final
volume as indicated: 7.5 µl water, 0.1 µl mixed forward and
reverse primers (0.25 µM each; MWG Biotech Fr, Champlan,
France), 0.4 µl Rox Reference Dye, and 10 µl Platinum SYBR
Green  qPCR  Super-Mix-UDG  (Invitrogen).  Next,  18  µl
aliquots were each added to 2 µl of cDNA (1:10 dilution) in
a reaction plate (Applied Biosystems, Applera France SA,
Courtaboeuf,  France)  .  Please  see  Table  1  for  detailed
information about primers.
Amplification  was  performed  using  an  Applied
Biosystems  7300  Real-Time  PCR  System.  The  following
conditions were used: 95 °C for 10 min (denaturation); 40
cycles of 95 °C for 15 s and 60 °C for 1 min (amplification
and quantification); and 95 °C for 15 s, 60 °C for 30 s, and
95 °C for 15 s (melting curve). Crossing points (CP) for each
transcript—the point at which the fluorescence is significantly
higher than background fluorescence—were determined for
subsequent analysis.
Cell cultures: Four or five WT or Tg mice were killed between
postnatal day 8 and 12 (PN8–12) by decapitation. Next, eyes
were  rapidly  enucleated,  transferred  into  Dulbecco’s
Modified Eagle Medium (DMEM; Invitrogen), and stored
overnight at room temperature in the dark. Intact globes were
then incubated in DMEM containing 2 mg/ml trypsin 250
(Invitrogen) and 2 mg/ml collagenase Type I (Worthington,
Coger, Paris, France) at 37 °C for 60 min. Globes were placed
in a Petri dish containing DMEM supplemented with 10%
fetal  calf  serum  (FCS;  Invitrogen),  1%  penicillin  and
streptomycin (Invitrogen), 1% L-glutamine (Invitrogen), and
0.1%  fungizone  (Invitrogen).  Retinas  were  removed,
mechanically dissociated into small pieces with forceps, and
seeded into 10 cm Petri dishes, each containing approximately
between  five  and  seven  retinas.  After  three  to  four  days,
medium  was  replaced  with  fresh  medium.  From  then  on,
medium was replaced every week. Pigmented eyes were used
for all experiments to monitor potential contamination by
foreign tissue, such as RPE or choroid. All cultures were
maintained  at  37  °C  in  a  humidified  incubator  with  5%
CO2/95% air. This is a recommended protocol for selection of
MG cells.
Enrichment of adherent cells and Müller glial cell passaging:
Once MG cells reached semiconfluence (five to seven days),
retinal aggregates and debris were removed by vigorously
pipeting medium onto the dish. This was repeated three to five
times to dislodge all aggregates. Cell cultures were split when
they were confluent. Cells were rinsed with calcium-free PBS
followed  by  a  brief  incubation  in  PBS  containing  0.05%
trypsin-EDTA (Invitrogen). The suspension was centrifuged
at 1,000 rpm for 10 min, cell pellets were resuspended, and
cells  were  seeded  at  12x103  cells/cm2  in  fresh  DMEM,
supplemented with 10% FCS, 1% penicillin and streptomycin,
1% L-glutamine, and 0.1% fungizone.
Müller glial cell immunocytochemistry: The homogeneity of
cell  cultures  from  WT  and  Tg  mice  was  evaluated  by
immunocytochemistry  with  the  specific  MG  cell  marker,
vimentin.  Subcellular  localization  of  mTf  and  hTf  was
determined using specific antibodies. First passage MG cells
grown  on  LabTek  chamber  slides  (VWR  International,
Strasbourg, France) were washed twice with PBS and fixed
with  4%  paraformaldehyde  for  15  min.  Cells  were
permeabilized with 0.1% Triton X-100 in PBS for 10 min and
blocked  with  1%  BSA  solution  for  30  min.  Primary
antibodies; rabbit anti-mTf, rabbit polyclonal anti-hTf, and
rabbit antivimentin were each diluted in PBS containing 0.5%
BSA. As per the aforedescribed procedure, MG cells were
treated with secondary antibodies for retinal sections.
Exposure of cells to iron: MG cells from WT and Tg mice
were incubated with 1:4 freshly prepared FeCl3-NTA solution
(François Canonne-Hergaux, Bichat, France). NTA is a small
molecular  weight  chelator,  sequestering  Fe3+  and  forming
hydrophobic complexes [30]. Cells were seeded at a density
of 12x103 cells/cm2 in 24 or 12 well plates and incubated in
DMEM containing 10% FCS, 1% penicillin and streptomycin,
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930Figure 1. Human transferrin is localized in the same cells in transgenic mice retina as in human retina. A: Non-immune serum was used as a
control. B-D: Human transferrin (hTf; green) localization was realized on frozen sections of one-month-old transgenic (Tg) mice retina. hTf
is localized in Müller glial (MG) cells and retinal pigment epithelium (RPE; B,C), identified with cellular retinaldehyde binding protein
(CRALBP; red; D), specific marker. C: Higher magnification of RPE from (B). E-F: hTf is localized in a 90-year-old human retina (E) in the
same cells as in Tg mice still identified by CRALBP (F). The following abbreviations are used: Ganglion cell layer (GCL), inner nuclear layer
(INL), inner plexifrom layer (IPL), inner segments (IS), outer limiting membrane (OLM), outer nuclear layer (ONL), outer plexifrom layer
(OPL), outer segments (OS), retinal pigmented epithelium (RPE). The scale bars in A,B, D-F equal 100 µM and the scale bar in C equals 10
µm.
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9311% L-glutamine, and 0.1% fungizone. Cells were counted
when  they  were  confluent  (after  three  days).  Cells  were
washed  in  PBS  and  incubated  in  serum-free  medium
containing FeCl3-NTA at a final concentration of 100 µM or
500 µM for 96 h. Cells incubated in medium without FeCl3-
NTA served as controls.
Figure 2. Mouse transferrin is synthetized and localized in one-month-old mouse retina. A: Non-immune serum was used as a control. B-C:
Mouse transferrin (mTf; green) is localized on frozen sections of wild-type (WT) mice (A,B) and in transgenic (Tg) mice (C). Scale bar equals
100 µM. The following abbreviations are used: Ganglion cell layer (GCL), inner nuclear layer (INL), inner plexifrom layer (IPL), inner
segments (IS), outer limiting membrane (OLM), outer nuclear layer (ONL), outer plexifrom layer (OPL), outer segments (OS), retinal
capillaries (RC), retinal pigmented epithelium (RPE). D: mTf concentration (ng/ml) was measured by radioimmunoassay (RIA) in supernatant
of retinal extracts of WT and Tg mice . Each column represents the mean ±SEM. The double asterisk represents statistical significance of
differences from control, p<0.01. E: mTf mRNA expression was quantified by RT-qPCR in retinal extracts from WT and Tg mice. Each
column represents the mean ±SEM. The asterisk represents statistical significance of differences from control, p<0.05.
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932Exogenous human transferrin treatment: MG cells from WT
mice were treated with exogenous human apo and holo-Tf
(Sigma). As per the aforedescribed protocol, first passage MG
cells  were  prepared,  before  iron  exposure.  Cells  were
incubated for 96 h in serum-free medium containing 100 µM
FeCl3-NTA with freshly prepared hTf solution added to final
concentrations of 2.5, 5, 10, and 20 ng/ml. Incubations with
the four hTf concentrations but without FeCl3-NTA were also
performed.  For  quantification  purposes,  cell  counts  for
cultures incubated without FeCl3-NTA were defined as 100%.
Cell number evaluation: Cells were counted using a Malassez
cell.  After  treatment,  cells  were  removed  from  plates  as
described in the next section. Cell pellets were resuspended
in DMEM containing 10% FCS. Suspension aliquots were
placed in a Malassez cell, and cells were counted under an
inverted microscope DMIRB (Leica) equipped with phase
contrast.  Results,  normalized  to  the  volume  of  the  cell
suspension, were expressed as percentages ±standard error of
MG cells under control conditions (without 100 µM FeCl3-
NTA), for WT and Tg mice.
Determination of cell viability: Cell viability was determined
by measuring lactate dehydrogenase (LDH) activity in the
incubation  medium  with  a  microtiter  plate  assay  (Nunc
distributed by VWR International). Next, 100 µl aliquots of
incubation medium were collected following iron stress and
incubated with 100 µl of Cytotoxicity Detection Kit reaction
mixture (Roche Diagnostics, Meylan, France) for 30 min at
room  temperature  in  the  dark.  The  optical  density  of  the
solution was measured on an ELISA plate reader with 492 and
620  nm  filters  (Benchmark  Plus  microplate
spectrophotometer,  BioRad,  Marnes-la-Coquettes,  France).
LDH activity in the incubation medium was compared with
that measured after complete lysis of the cells in medium
containing 2% Triton X-100. A viability percentage of zero
corresponded to 100% LDH activity in the medium.
Transferrin quantification and RT-qPCR analysis of human
transferrin  and  mouse  transferrin:  hTf  and  mTf  were
measured  by  ELISA  and  RIA,  respectively,  in  MG  cell
medium and in MG cells (from WT and Tg mice) following
iron stress treatment, according to the method described for
hTf and mTf retinal extract measurements.
For RT-qPCR analysis, MG cells, treated with or without
iron, were lysed in buffer and lysates were frozen at −80 °C.
Methods used were as described in the previous section for
RT-qPCR analysis of retinal extracts.
Statistical  analysis:  Results  were  presented  as  mean
±standard error of the mean. We used the Mann–Whitney U-
test  to  evaluate  differences  between  Tg  and  WT  mice.
Analysis was performed using GraphPad Prism 4 software. A
p<0.05  was  considered  statistically  significant.  Each
experimental condition was repeated three or four times, and
MG cells used were from different primary cell cultures.
RESULTS
Characterization  of  transgenic  mice  and  detection  of
transferrin protein and mRNA: hTf protein was detected in Tg
mouse retina by immunohistochemistry. hTf was observed in
the  RPE  layer  and  MG  cells  identified  by  CRALBP
immunoreactivity, a specific marker for MG cells (Figure 1B,
D). hTf was present in MG cell bodies within the inner nuclear
layer and in MG cell processes that form radial extensions
through the retina. hTf in human retina sections had the same
distribution (Figure 1E-F). These findings were confirmed by
the detection of hTf protein and mRNA in Tg mouse retina by
ELISA and RT-qPCR (data not shown). hTf in Tg mouse
retina was detected at early stages of development (postnatal
day 1) and its localization pattern correlated with MG cell
differentiation during embryonic and postnatal development
(data not shown).
For both WT and Tg mice, we demonstrated that mTf
protein was present in the outer segments (OS) and, to a lesser
extent, in the inner segments (IS) of photoreceptors, in the thin
layer of RPE cells and in astrocytes of the ganglion cell layer
(GCL;  Figure  2B-C).  mTf  immunoreactivity  was  also
detected in retinal capillaries, choroid, and sclera. Diffuse mTf
immunoreactivity was evident throughout both WT and Tg
mice retinas during the first days of development; mTf then
became localized to the cellular layers. The patterns of mTf
immunoreactivity in WT and Tg mice were similar throughout
development (data not shown).
mTf protein was detected in retinal extracts from both
WT and Tg mice using ELISA and RIA. However, levels of
mTf were significantly higher in Tg mouse retina than in WT
(Figure 2D). Consistent with these results, mTf mRNA was
detected in both WT and Tg mice neural retina using RT-
qPCR. mTf mRNA levels were significantly higher in Tg
mouse retina than in WT retina (Figure 2E).
Transferrin  synthesis  in  Müller  glial  cells  in  vitro:  To
investigate the role of hTf in Tg mouse retina, we isolated MG
cells from PN8–12 WT and Tg mice and cultured them as
described in methods [31]. All cells from both mouse types
were vimentin immunoreactive (vimentin is a specific marker
of MG cells) in primary cultures (Figure 3A,B) as well as in
subcultures (results not shown).
mTf  and  hTf  protein  was  detected  by
immunocytochemistry in MG cells from WT and Tg mice.
Both mTf and hTf were detected in the cytoplasm of MG cells
(Figure 3C-E). However, even in primary cultures, there was
some heterogeneity in the levels of protein present.
Media from primary cultures and subsequent passages of
WT and Tg MG cells were assayed for hTf and mTf by ELISA
and RIA, respectively. mTf concentration in Tg mice-derived
primary culture medium was significantly twice that in WT
mice-derived cell medium (Figure 4A). The concentration of
hTf  in  MG  cells  from  Tg  mice  was  10  times  the  mTf
concentration (Figure 4B). In WT and Tg mice-derived MG
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933cells,  mTf  and  hTf  concentrations  significantly  decreased
progressively with the number of passages, such that Tf levels
were undetectable by the third passage.
Effects of iron stress on Müller glial cell viability in culture:
To test the response of MG cells from WT and Tg mice to a
metabolic stress, MG cell cultures (passages one and three)
were treated with two concentrations of 1:4 FeCl3-NTA (100
and 500 µM) in serum-free medium. The number of MG cells
in first passage WT cultures treated with 100 µM FeCl3-NTA
was 35% lower (p<0.0007) than in untreated WT cultures.
Conversely, cell counts in Tg cultures treated with this same
concentration of FeCl3-NTA were not significantly different
from those in untreated cultures (Figure 5A). However, cell
counts in cultures treated with 500 µM of FeCl3-NTA were
less than 50% of those in untreated cultures (data not shown).
Third passage cell cultures, with barely detectable hTf and
mTf levels, treated with 100 µM FeCl3-NTA, had a 60% lower
survival rate than untreated third passage cultures (data not
shown).
LDH activity was assayed in the medium of FeCl3-NTA-
treated, first passage WT MG cells to evaluate cell death. LDH
activity was 8.6% significantly higher (p<0.002) in media
Figure 3. Mouse transferrin and human transferrin are present in
Müller glial cells from 8- to 12-day-old wild-type and transgenic
mice. A-B: Müller glial (MG) cells in culture from wild-type (WT;
A)  and  transgenic  (Tg;  B)  mice  were  identified  with  vimentin
staining (red) specific marker. C-E: Mouse transferrin (mTf; C,D)
and human transferrin (hTf; E; green) were localized in MG cells
from WT (C) and Tg (D,E) mice. Scale bar: 100 µm.
from cells treated with 100 µM of FeCl3-NTA than in media
from  untreated  WT  controls.  Conversely,  there  was  no
Figure 4. Transferrin secretion in medium of Müller glial cells from
8 to 12-day-old wild-type and transgenic mice decreases with the
subcultures. A: Mouse transferrin (mTf) secretion in medium of
cultured Müller glial (MG) cells from wild-type ( WT) and transgenic
(Tg) mice at confluency after primary culture (P0) and at the first
(P1)  and  the  second  passages  (P2)  was  measured  by
radioimmunoassay (RIA; ng/ml). Each column represents the mean
±SEM. The asterisk represents statistical significance of differences
between WT and Tg at P0, p<0.05. The triple asterisk represent
statistical significance of differences from WT and Tg mice betwen
P1 and P2 compared to P0 and between P1 and P2 themselves,
p<0.001.  B:  Human  transferrin  (hTf)  secretion  in  medium  of
cultured MG cells from WT and Tg mice at confluency after primary
culture  (P0)  and  at  the  first  (P1)  and  the  second  passages  (P2)
was measured by ELISA assay (ng/ml). Each column represents the
mean  ±SEM.  The  asterisk  represents  statistical  significance  of
differences  from  P0,  p<0.05.  The  double  asterisk  represents
statistical  significance  of  differences  from  WT  and  Tg  mice
betwen  P1  and  P2  compared  to  P0  and  between  P1  and  P2
themselves, p<0.0.1.
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934significant difference between LDH activity in media of hTf
Tg-derived MG cells treated with 100 µM FeCl3-NTA and
that in untreated Tg cell media (Figure 5B).
Effects  of  iron  stress  on  mouse  and  human  transferrin
expression in Müller glial cells: MG cell culture media from
WT and Tg mice were collected after 96 h of iron stress and
mTf  and  hTf  concentrations  were  measured  by  RIA  and
ELISA. The mTf concentration in the medium of untreated
Tg-derived MG cells was significantly higher (p<0.002) than
in the medium of untreated cells from WT mice (Figure 6A).
However,  there  was  no  significant  difference  in  mTf
concentration between cell culture media treated with and
without 100 µM of FeCl3-NTA for either WT or Tg mice.
Moreover, the hTf concentration in Tg mice MG cell culture
media was fivefold higher than mTf concentration. The hTf
concentration in the medium of Tg cells treated with 100 µM
FeCl3-NTA was 50% lower than that in untreated Tg cell
medium  (Figure  6B).  In  cell  lysates,  mTf  and  hTf  were
undetectable (data not shown).
RT-qPCR was used to determine intracellular mTf and
hTf mRNA levels WT and Tg cell cultures following 96 h of
iron stress. mTf mRNA was significantly more abundant in
MG cells from Tg mice than in those from WT mice, whether
treated or untreated (Figure 7A). MG cells from WT mice
treated  with  100  µM  of  FeCl3-NTA  had  a  significantly
(p<0.002)  lower  level  of  mTf  mRNA  expression  than
untreated  WT  cells,  whereas  there  was  no  significant
difference between treated and untreated cells from Tg mice.
However,  Tg  cells  treated  with  100  µM  FeCl3-NTA  had
significantly  lower  (p<0.002)  hTf  mRNA  levels  than
untreated Tg cells (Figure 7B).
Addition of exogenous human transferrin in medium of Müller
glial cells from wild-type mice after iron stress: We added 2.5,
5, 10, and 20 ng/ml commercial human apo-Tf to WT MG cell
culture media containing 100 µM of FeCl3-NTA to investigate
the potential protective effect of human apo-Tf on WT MG
cells. Addition of only exogenous human apo-Tf had no effect
on MG cell numbers, even at the highest concentrations (data
not shown). However, cells treated with 100 µM of FeCl3-
NTA and 2.5 ng/ml human apo-Tf had a significantly higher
survival rate (92%) than iron-treated cells without addition of
exogenous human apo-Tf (70%). Cells with 5, 10, and 20 ng/
ml of human apo-Tf added to medium containing 100 µM of
FeCl3-NTA had survival rates that were 35% to 43% higher
than those with FeCl3-NTA alone. There was no significant
difference between cells with and without exogenous human
apo-Tf in the absence of iron (Figure 8). To compare the
protective effects of human apo-Tf on WT MG cells, we also
added 2.5, 5, 10, and 20 ng/ml commercial human holo-Tf to
WT MG cell culture media containing 100 µM of FeCl3-NTA.
Addition  of  exogenous  human  holo-Tf  alone  at  the
concentration of 2.5 ng/ml had no significative effect on MG
cell numbers. At the highest concentrations (10 and 20 ng/ml),
human holo-Tf alone diminished significantly the number of
cells compared to condition without iron added (Figure 9A).
Cells treated with 100 µM of FeCl3-NTA and 2.5 and 5 ng/ml
Figure 5. Müller glial cells from transgenic mice are more resistant
to iron-mediated stress than Müller glial cells from wild-type mice.
A: Culture of Müller glial (MG) cells from wild-type (WT) and
transgenic (Tg) mice at the first passage were treated with 100 µM
of FeCl3-NTA (FN), during 96 h. The number of cells was evaluated
by  counting  in  comparison  to  control  condition.  Each  column
represents the mean ±SEM. The triple asterisk represent statistical
significance of differences between treated and control, respectively,
for WT and Tg, and between control and treated, p<0.001. B: Release
of lactate dehydrogenase (LDH) was measured after incubation of
MG cells with 100 µM of FN. The percent (%) release of LDH from
MG  cells  was  reported  to  the  total  LDH  release.  Each  column
represents the mean ±SEM. The double asterisk represents statistical
significance of differences from control, p<0.01 In both figures, data
considered not significant is marked NS.
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935human holo-Tf had a significantly higher survival rate (98 and
83%) than iron-treated cells without addition of exogenous
human holo-Tf (70%). Nevertheless, 10 and 20 ng/ml human
holo-Tf added to media with 100 µM of FeCl3-NTA had no
significative effect on survival rate (Figure 9B) compared to
iron-treated cells.
DISCUSSION
Iron is an essential component of cell survival [1], but its
capacity to generate highly reactive hydroxyl free radicals via
the Fenton reaction can also render it toxic to cells. Iron
accumulates in the retina during aging [11,12] and in some
retinal degenerative animal models [13,14]. Many proteins
such  as  ferritin,  transferrin  receptor,  and  transferrin  are
involved in regulating iron status. Tf can transport two ferric
ions  per  molecule  across  the  cell  membrane,  rendering  it
protective against toxic effects of labile iron. We investigated
the regulation of Tf levels in WT and Tg mice. The 16 months-
old Tg mice have an apparently normal phenotype, although
they have low testicular sperm reserves that do not affect
fertility  [27].  Retinal  structure  was  not  affected  and  mTf
localization was similar in WT and Tg mice in the RPE cell
layer, photoreceptor layer, and ganglion cell layer. This same
pattern of localization has been described in rat retina [10].
However, in Tg mice, most hTf was in MG and RPE cells,
identified  using  specific  markers.  This  pattern  of  hTf
localization is also observed in human retina; the fact that Tg
mice  express  the  hTf  gene  under  the  control  of  its  own
promoter may explain this similarity [26].
Expression of hTf transgene seemed to affect endogenous
mTf  production.  Indeed,  Tg  retinal  extracts  contained
significantly more endogenous mTf proteins and mRNA than
WT retinal extracts in Tg mice. Similar findings have been
reported in Sertoli cells and the brain [25].
We cultured MG cells from Tg and WT mice to determine
where  Tf  is  synthesized  and  transported.  MG  cells  were
positively  identified  in  all  cultures,  using  vimentin  as  a
specific marker. hTf immunoreactivity was detected in the
cytoplasm  of  MG  cells  from  Tg  mice  and  in  the  culture
medium. mTf was also detected in the cytoplasm and media
of  both  WT  and  Tg  MG  cells.  mTf  production  may  be
activated in these cells as a stress response caused by culture.
In retina from diabetic rats, MG cells upregulate many genes
associated with inflammation including Tf [32].
MG cells synthesize and secrete mTf and hTf but lose this
ability as the number of passages increase, suggesting that hTf
and endogenous mTf promoters have similar activities and are
similarly regulated. mTf and hTf promotors both contain the
cis-acting  regulatory  elements  PRI  and  PRII,  which  are
similar in the two species [33]. The proximal promoter regions
of both hTf and mTf contain a CCAAT consensus sequence
that binds to members of the CAAT enhancer-binding protein
family of transcription factors [34].
Despite these similarities, there was some discrepancy in
Figure  6.  Mouse  transferrin  and  human  transferrin  proteins
expression are modulated after iron stress. A: Mouse transferrin
(mTf) secretion was measured by radioimmunoassay (RIA) in the
culture medium of Müller glial (MG) cells from wild-type (WT) and
transgenic (Tg) mice in control condition or after addition of 100 µM
of FeCl3-NTA (FN) during 96 h. Each column represents the mean
±SEM.  The  double  asterisk  represents  statistical  significance  of
differences between treated and control, respectively, for WT and
Tg, p<0.01. B: Human transferrin (hTf) secreted was quantified by
ELISA assay in the culture medium of MG cells from Tg mice in
control condition or after addition of 100 µM of FN during 96 h. Each
column represents the mean ±SEM. The double asterisk represents
statistical significance of differences from control, p<0.01 In both
figures, data considered not significant is marked NS.
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936the expression of both hTf and mTf in MG cells between Tg
and  WT  mice,  which  probably  corresponds  to  several
differences between hTf and mTf promoter sequences [35].
We observed there was significantly more hTf protein than
Figure 7. Mouse transferrin and human transferrin mRNA expression
are modified after iron stress. A: Mouse transferrin (mTf) mRNA
expression was quantified by RT-qPCR in Müller glial (MG) cells
respectively  from  wild-type  (WT)  and  transgenic  (Tg)  mice  in
control condition and after addition of 100 µM FeCl3-NTA (FN) in
the medium during 96 h. Each column represents the mean ± SEM.
The  double  asterisk  represents  statistical  significance  of
differences between treated and control, respectively, for WT and
Tg, and between control and treated, p<0.01. B: Human transferrin
(hTf) mRNA expression was quantified by RT-qPCR in MG cells,
respectively, from Tg mice in control condition and after addition of
100 µM FN in the medium during 96 h. Each column represents the
mean  ±SEM.  The  double  asterisk  represents  statistical
significance of differences from control, p<0.01 In both figures, data
considered not significant is marked NS.
mTf protein in retinal extract and culture media of MG cells
from Tg mice. Thus, mechanisms regulating hTf and mTf are
not identical in these Tg mice. Our findings of differences in
localization patterns are consistent with this. In the rat brain,
Tf mRNA is observed in oligodendrocytes [36] and epithelial
cells of the choroid plexus [18]. By contrast, Tf mRNA is not
observed in the human choroid plexus [19]. Moreover, hTf
transgene is inserted in the F1 area of the chromosome 12
[27]  and  the  number  of  copies  is  nearly  12  (F.  Guillou,
personal communication), which could explain the specificity
of expression noticed.
Tf has many functions; most are related to its Fe3+-binding
and -transporting properties, rendering it a potent antioxidant.
In renal ischemia-reperfusion injury, Tf lowers the circulating
redox-active iron levels [37]. Tf has potent anti-apoptotic/
cytoprotective  effects  against  Fas-mediated  signals  in
hepatocytes and lymphohemopoietic cells [38,39]. In a rabbit
model of after-cataract formation following cataract surgery,
Tf synthesis is upregulated in lens epithelia acting as a survival
and proliferative factor [40]. These properties can be used to
prevent iron accumulation and free radical formation by the
Fenton reaction in many situations [37]. For example, ovoTf
Figure  8.  Exogenous  human  apo-transferrin  protects  Müller
glial cells from wild-type mice from iron-induced stress. The Müller
glial (MG) cells from wild-type (WT) mice at the first passage were
treated with 100 µM of FeCl3-NTA (FN) in presence or absence of
different concentrations (2.5, 5, 10, and 20 ng/ml) of human apo-
transferrin (h apo-Tf). Their number was determined by counting in
comparison to control condition. Each column represents the mean
±SEM.  The  asterisk  represents  statistical  significance  of
differences from FN alone, p<0.05. Data considered not significant
compared to control are marked NS.
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937is  a  survival  and  growth-promoting  factor  [41].  Tf  may
function  as  a  neurotransmitter  or  neuromodulator  in  the
developing vertebrate nervous system [42]. In addition, MG
cells mediate nerve cell protection [43–45]. Moreover, MG
cells are potential regenerative stem/precursor cells involved
in neural retina regeneration response in vertebrates following
lesion [46,47].
We  subjected  these  cells  to  iron-induced  stress  using
NTA, increasing levels of bound and unbound iron in the
cytoplasm  [46–48]  without  activation  of  the  classical  Tf
receptor endocytosis pathway [49,50].
We observed that treatment with 100 µM FeCl3-NTA did
not affect survival of Tg MG cells during the first passage,
whereas there were 35% fewer cells in WT cultures following
treatment  with  100  µM  FeCl3-NTA  than  there  were  in
untreated WT cultures. During the third passage of Tg MG
cells, hTf could no longer be detected in the medium and the
effects of iron treatment were similar in cells from both WT
and Tg mice. Cell survival correlated with hTf concentration
during the subculture. Moreover, WT MG cells treated with
human apo-Tf but not human holo-Tf were protected against
100 µM FeCl3-NTA. Unlike human holo-Tf, WT MG cells
survival against iron treatment is correlated to the capacity of
human apo-Tf to catch iron in excess. Human holo-Tf, which
probably  is  not  fully  saturated  with  iron,  seemed  to  be
protective at the lowest concentrations (2.5 and 5 ng/ml). At
the highest concentrations (10 and 20 ng/ml), it seemed to be
toxic because its iron loads were higher.
We quantified the levels of Tf protein and mRNA in
serum-free medium to assess the effects of iron-induced stress
on hTf and mTf metabolism in MG cells. As expected mRNA
levels were slightly lower for mTf and markedly lower for hTf
in the presence than absence of iron. The molecular basis for
the lower levels of hTf following iron administration has not
been extensively studied. In humans, anemia resulting in iron
deficiency is associated with high plasma Tf levels whereas
conditions resulting in excess iron stores are associated with
low  plasma  Tf  [51].  The  low  plasma  Tf  concentration
associated with increased iron stores in humans may be due
to the effects of negative feedback on Tf synthesis [52].
Tf gene transcription is induced by a variety of factors in
a tissue-specific manner. In rats and chickens, nutritional iron
deficiency activates Tf gene transcription specifically in the
liver, resulting in a several-fold increase in Tf synthesis [53,
54]. In human hepatoma HepG2 cells lines, iron treatment
suppresses Tf synthesis demonstrating regulation of intact
endogenous Tf synthesis by iron [54]. Previous studies on
transgenic mice have identified a 50 nucleotide region in the
5′UTR of hTf mRNA involved in hTf iron regulation. Within
this region, an an iron responsive element (IRE)- homologous
sequence (“the putative hTf IRE”) was identified [55].
The high level of hTf in the medium of hTf Tg MG cells
may be a protective mechanism against the labile iron pool.
Tf  sequestrates  iron  from  the  FeCl3-NTA  added  to  the
Figure 9. Exogenous human holo-transferrin does not protect Müller
glial cells from wild-type mice from iron-induced stress. A,B: The
number of Müller glial (MG) cells from wild-type (WT) mice in
culture at the first passage after treatment with 100 µM of FeCl3-
NTA (FN), during 96 h was evaluated by counting in comparison to
control condition A: The MG cells from WT mice at the first passage
were treated with different concentrations (2.5, 5, 10, and 20 ng/ml)
of human holo-transferrin (h holo-Tf). Their number was determined
by  counting  in  comparison  to  control  condition.  Each  column
represents  the  mean  ±SEM.  The  asterisk  represents  statistical
significance of differences for treated by h holo-Tf alone in relation
respectively to control and to treated by FN alone, p<0.05 Data
considered not significant compared to control or to treated by FN
alone is marked NS. B: The MG cells from WT mice at the first
passage were treated with 100 µM of FN in presence of different
concentrations (2.5, 5, 10, and 20 ng/ml) of h holo-Tf in the medium.
Their number was determined by counting in comparison to control
condition. Each column represents the mean ±SEM. The asterisk
represents statistical significance of differences for treated by h holo-
Tf after FN in relation, respectively, to control and to treated by FN
alone, p<0.05. Data considered not significant compared to control
or to treated by FN alone is marked NS.
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938medium,  preventing  iron  toxicity.  The  use  of  FeCl3-NTA
permits direct entry of iron into the MG cells where it is stored
by ferritin. Iron excess inhibits activation of Tf transcription.
Very low levels of hTf mRNA may result from transcription
factors  binding  specific  hTf  promoter  sequences.  hTf  can
regulate its transcription directly or indirectly in an autocrine
manner. hTf is an autocrine factor for the development and
maturation of oligodendrocytes [56]. In humans, Tf produced
by T cells can function in an autocrine manner rather than a
paracrine manner [57]. Tf synthesis in small cell lung cancer
cells  also  acts  as  an  autocrine  regulator  of  cellular
proliferation, allowing these cells to continue proliferating
under transferrin-free conditions [58].
In our study, isolated MG cells from Tg mice expressing
hTf were protected against iron-mediated stress. We believe
that hTf regulates its transcription in an autocrine manner to
control intracellular iron levels. These findings are consistent
with a potential protective role for Tf in retina, which is related
to the capacity of Tf to bind iron. Thus, therapeutic targeting
of retinal Tf may be beneficial in pathological conditions
involving  iron  accumulation  such  as  aging,  AMD,  and
inflammation.
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